Cytokeratin 14 as a marker of squamos differentiation in transitional cell carcinomas

Journal of Clinical Pathology

Volumn 50, Issue 12, 1997, Pages 1032-1033

  Harnden, P ^a   Southgate, J ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cytokeratins; Squamos differentiation; Transitional cell carcinomas

Indexed keywords

CYTOKERATIN;

ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL DIFFERENTIATION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SQUAMOUS CELL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0031441059     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.12.1032     Document Type: Article

References (10)

1. Moll R. Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 1994;9:63-9.
2. Harnden P, Eardley I, Joyce AD, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 1996;78:870-5.
3. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
4. Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest 1985;52:243-56.
5. Tannenbaum SI, Carson CC, Tatum A, Paulson DF. Squamous carcinoma of urinary bladder. Urology 1983;22: 597-9.
6. Jenkins BJ, Martin JE, Baithun SI, Zuk RJ, Oliver RT, Blandy JP. Prediction of response to radiotherapy in invasive bladder cancer. Br J Urol 1990;65:345-8.
7. Vale JA, A'Hern RP, Liu K, Hendry WF, Whitfield HN, Plowman PK, et al. Predicting the outcome of radical radiotherapy for invasive bladder cancer. Eur Urol 1993;24: 48-51.
8. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 1994;71:583-94.
9. Byrne C, Tainsky M, Fuchs H. Programming gene expression in developing epidermis. Development 1994;120: 2369-83.
10. Cress AH, Dalton WS. Multiple drug resistance and intermediate filaments. Cancer Med Rev 1996;15:499-506.